Key statistics
On Monday, X T L Biopharmaceuticals Ltd (XTLB:TLV) closed at 2.00, 5.26% above its 52-week low of 1.90, set on Feb 24, 2026.
52-week range
| Open | 2.20 |
|---|---|
| High | 2.20 |
| Low | 2.00 |
| Bid | 2.00 |
| Offer | 2.10 |
| Previous close | 2.20 |
| Average volume | 4.08m |
|---|---|
| Shares outstanding | 946.24m |
| Free float | 911.77m |
| P/E (TTM) | -- |
| Market cap | 20.91m ILS |
| EPS (TTM) | -0.3198 ILS |
Data delayed at least 20 minutes, as of Mar 02 2026 14:40 GMT.
More ▼
- XTL Announces Receipt of Staff Delist Determination from Nasdaq and Plans to Request Hearing
- XTL Update on Recent Developments
- XTL Announces Receipt of Nasdaq Notification Regarding Minimum Stockholders’ Equity Deficiency
- XTL Biopharmaceuticals Acquires 85% of NeuroNOS, Entering the Massive Autism Market with Nobel Prize-Winning Scientific Leadership
- XTL Announces Receipt of Nasdaq Notification Letter Regarding Minimum Bid Price Deficiency
- XTL Names Mr. Noam Band as its New Chief Executive Officer
More ▼
